PPL
54
-5
CINF
53
2
NRG
49
-3
XRAY
28
2
DG
6
2
CRM
67
2
GIS
31
3
ROP
62
3
HCA
44
-2
NAVI
52
5
MAT
46
12
DFS
64
2
RL
72
4
YUM
47
3
EOG
58
2
A
43
2
LEG
36
4
PLD
56
8
LMT
34
2
BSX
67
-3
PPL
54
-5
CINF
53
2
NRG
49
-3
XRAY
28
2
DG
6
2
CRM
67
2
GIS
31
3
ROP
62
3
HCA
44
-2
NAVI
52
5
MAT
46
12
DFS
64
2
RL
72
4
YUM
47
3
EOG
58
2
A
43
2
LEG
36
4
PLD
56
8
LMT
34
2
BSX
67
-3
Financhill
Back

Amneal Pharmaceuticals 10K Form

Buy
55

AMRX
Amneal Pharmaceuticals

Last Price:
8.40
Seasonality Move:
18.58%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AMRX News And Ratings

See the #1 stock for the next 7 days that we like better than AMRX

AMRX Financial Statistics

Sales & Book Value

Annual Sales: $2.39B
Cash Flow: $121.06M
Price / Cash Flow: 10.8
Annual Sales: $-0.30
Price / Book: 0

Profitability

EPS (TTM): -0.68050
Net Income (TTM): $-184.45M
Gross Margin: $820.57M
Return on Equity: -587.3%
Return on Assets: -5.24%

Amneal Pharmaceuticals Earnings Forecast

Key Amneal Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 8 years for AMRX is 34.28%.
  • The Selling, General & Administrative Expenses for AMRX have been equal to 17.95% of Gross Profit Margin.
  • The Research & Development expenses have been 7.01% of Revenue.
  • The Interest Expense is -250.77% of Operating Income.
  • The Net Earning history of AMRX is -3.51% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 2 years.

Amneal Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: AMRX
CUSIP: 03168L
Website: amneal.com

Debt

Debt-to-Equity Ratio: -27.12
Current Ratio: 1.38
Quick Ratio: 0.79

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 11.51

AMRX Technical Analysis vs Fundamental Analysis

Buy
55
Amneal Pharmaceuticals (AMRX) is a Buy

Is Amneal Pharmaceuticals a Buy or a Sell?